Wealth Enhancement Trust Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.24M Sell
5,392
-579
-10% -$683K 0.67% 40
2026
Q2
$7.16M Sell
5,971
-751
-11% -$767K 0.8% 32
2026
Q1
$6.18M Sell
6,722
-410
-6% -$416K 0.75% 32
2025
Q4
$7.66M Buy
+7,132
New +$6.82M 0.97% 24

Other funds holding LLY

Wealth Enhancement Trust Services's LLY Position: Q3 2026 in Review

Wealth Enhancement Trust Services reduced its Eli Lilly (LLY) stake by 9.7% in Q3 2026, selling an estimated $683K and leaving 5,392 shares worth $6.24M. The position accounts for 0.67% of the portfolio, ranked #40.

Wealth Enhancement Trust Services first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.66M in Q4 2025. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Wealth Enhancement Trust Services held 5,392 shares of Eli Lilly worth $6.24M as of Q3 2026.
  • Wealth Enhancement Trust Services sold 579 Eli Lilly shares in Q3 2026, an estimated $683K.
  • Eli Lilly made up 0.67% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #40 holding.
  • Wealth Enhancement Trust Services first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Trust Services's Eli Lilly position peaked at $7.66M in Q4 2025.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.